首页> 外国专利> METHOD FOR THERAPY EFFECTIVENESS PREDICTION FOR PATIENTS WITH CORONARY ARTERY DISEASE 12 MONTHS AFTER ACUTE CORONARY SYNDROME

METHOD FOR THERAPY EFFECTIVENESS PREDICTION FOR PATIENTS WITH CORONARY ARTERY DISEASE 12 MONTHS AFTER ACUTE CORONARY SYNDROME

机译:急性冠脉综合征术后12个月冠心病患者的治疗效果预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to therapy effectiveness prediction for patients with coronary artery disease 12 months after an acute coronary syndrome (ACS). To do this, 12 months after ACS, level of vascular endothelial growth factor (VEGF-A), and endostatinthe is investigated in the blood of patients who are committed to drug therapy. In case if the level of VEGF-A exceeds 155.13 pg/ml, and the endostatin level exceeds 266.39 ng/ml, low effectiveness of drug therapy is predicted.;EFFECT: improved prediction accuracy, which in turn allows timely correction of medication.;2 tbl,1 ex
机译:发明领域本发明涉及对急性冠脉综合征(ACS)后12个月的冠心病患者的治疗效果预测。为此,在接受药物治疗的患者血液中调查了ACS后12个月的血管内皮生长因子(VEGF-A)和内皮抑素的水平。如果VEGF-A的水平超过155.13 pg / ml,内皮抑素的水平超过266.39 ng / ml,则预测药物治疗的有效性较低。效果:预测准确性提高,从而可以及时纠正药物。 2 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号